Fundraising Fox

Delcath Systems

NASDAQ: DCTH

Ny, US · Founded 1987 · Delaware corporation · 151 employees on LinkedIn

Biotech

Founders & leadership

BK
Barbra KeckExecutive
JS
Jennifer SimpsonExecutive
MT
Marco TagliettiNamed on SEC filing

Board

RS
Roger StollBoard director
WR
William RueckertBoard director

Reported raises · per SEC filings

Form D private placements

$71.9M disclosed across 7 rounds · 2018–2024

▶$7MraisedMar 2024 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven SalamonDirector
  • Elizabeth CzerepakDirector
  • Vojo VukovicExecutive Officer
  • Gerard MichelExecutive Officer, Director
  • Gilad AharonDirector
  • Roger G. StollDirector
  • Martha RookExecutive Officer
  • David J. HoffmanExecutive Officer
  • Kevin MuirExecutive Officer
  • John R. SylvesterDirector
  • Sandra PennellExecutive Officer
Offering amount
$7M
Amount sold
$7M
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25MraisedMar 2023 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gerard MichelExecutive Officer, Director
  • Kevin MuirExecutive Officer
  • Anthony DiasExecutive Officer
  • John PurpuraExecutive Officer
  • Elizabeth CzerepakDirector
  • Gilad AharonDirector
  • Johnny JohnExecutive Officer
  • Steven SalamonDirector
  • David HoffmanExecutive Officer
  • Roger G. StollDirector
  • John R. SylvesterDirector
Offering amount
$25M
Amount sold
$25M
Sales commissions
$1.5M
Placement agents
Canaccord Genuity LLC, Roth Capital Partners, LLC, BTIG, LLC
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.8MraisedDec 2022 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin MuirExecutive Officer
  • Gilad AharonDirector
  • David HoffmanExecutive Officer
  • John R. SylvesterDirector
  • Roger G. StollDirector
  • Anthony DiasExecutive Officer
  • Gerard MichelExecutive Officer, Director
  • Johnny JohnExecutive Officer
  • Steven SalamonDirector
  • John PurpuraExecutive Officer
  • Elizabeth CzerepakDirector
Offering amount
$3.8M
Amount sold
$3.8M
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedJul 2022 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Johnny JohnExecutive Officer
  • Steven SalamonDirector
  • Gerard MichelExecutive Officer, Director
  • Gilad AharonDirector
  • John R. SylvesterDirector
  • Elizabeth CzerepakDirector
  • Roger G. StollDirector
  • Anthony DiasExecutive Officer
  • David HoffmanExecutive Officer
  • John PurpuraExecutive Officer
  • Kevin MuirExecutive Officer
Offering amount
$5M
Amount sold
$5M
First sale
Jul 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.5MraisedAug 2019 · 33 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John R SylvesterDirector
  • Jennifer K SimpsonExecutive Officer, Director
  • Barbra C KeckExecutive Officer
  • John PurpuraExecutive Officer
  • William D RueckertDirector
  • Roger G StollDirector
  • Marco TagliettiDirector
Offering amount
$9.5M
Amount sold
$9.5M
Sales commissions
$738.3K
Placement agents
Roth Capital Partners, LLC
First sale
Aug 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedJul 2019 · 31 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Marco TagliettiDirector
  • Roger G StollDirector
  • Jennifer K SimpsonExecutive Officer, Director
  • Barbra C KeckExecutive Officer
  • John PurpuraExecutive Officer
  • William D RueckertDirector
Offering amount
$20M
Amount sold
$20M
Sales commissions
$1.4M
Proceeds to insiders
$500K
Placement agents
Roth Capital Partners, LLC
First sale
Jul 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.6MraisedAug 2018 · 1 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Roger StollDirector
  • Barbra KeckExecutive Officer
  • Jennifer SimpsonExecutive Officer, Director
  • William RueckertDirector
  • Marco TagliettiDirector
Offering amount
$1.6M
Amount sold
$1.6M
Minimum investment
$1M
Sales commissions
$208K
Placement agents
Roth Capital Partners, Advisory Group Equity Services Ltd.
First sale
Jul 2018
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Delcath Systems raised?
Delcath Systems has disclosed $71.9M raised across 7 rounds.
Where is Delcath Systems headquartered?
Delcath Systems is headquartered in Ny, US.